HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Erythron in patients with polycythemia vera during treatment by erythrocytapheresis and bloodletting].

Abstract
An analysis of the results of determination of erythropoietin in the blood plasma of patients with polycythemia vera and data on the kinetics of erythroid cell proliferation led to a conclusion that erythrocytapheresis more than bloodletting stimulated the production of erythropoietin and the cell proliferative potential. Activation of regenerative processes probably determined by deinhibition of the normal clone of bone marrow erythroid cells, can account for the mechanism of a therapeutic effect of erythrocytapheresis in patients with polycythemia vera.
AuthorsV I Gudim, T G Sarycheva, V M Kotel'nikov, A L Melikian, V S Ivanova
JournalTerapevticheskiĭ arkhiv (Ter Arkh) Vol. 59 Issue 6 Pg. 48-51 ( 1987) ISSN: 0040-3660 [Print] USSR
Vernacular TitleEritron u bol'nykh istinnoĭ politsitemieĭ v protsesse lecheniia éritrotsitaferezom i krovospuskaniiami.
PMID3629498 (Publication Type: English Abstract, Journal Article)
Topics
  • Blood Component Removal
  • Bloodletting
  • Erythrocytes
  • Erythropoiesis
  • Humans
  • Polycythemia Vera (blood, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: